EP2467059B1 - Dispositif portatif pour myographie d impédance électrique - Google Patents

Dispositif portatif pour myographie d impédance électrique Download PDF

Info

Publication number
EP2467059B1
EP2467059B1 EP10748158.2A EP10748158A EP2467059B1 EP 2467059 B1 EP2467059 B1 EP 2467059B1 EP 10748158 A EP10748158 A EP 10748158A EP 2467059 B1 EP2467059 B1 EP 2467059B1
Authority
EP
European Patent Office
Prior art keywords
electrodes
tissue
region
eim
pair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP10748158.2A
Other languages
German (de)
English (en)
Other versions
EP2467059A1 (fr
Inventor
Seward B. Rutkove
Joel Lawrence Dawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Massachusetts Institute of Technology
Original Assignee
Beth Israel Deaconess Medical Center Inc
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc, Massachusetts Institute of Technology filed Critical Beth Israel Deaconess Medical Center Inc
Publication of EP2467059A1 publication Critical patent/EP2467059A1/fr
Application granted granted Critical
Publication of EP2467059B1 publication Critical patent/EP2467059B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4519—Muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6843—Monitoring or controlling sensor contact pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
    • A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
    • A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0266—Operational features for monitoring or limiting apparatus function
    • A61B2560/0276—Determining malfunction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
    • A61B2562/0215—Silver or silver chloride containing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04—Arrangements of multiple sensors of the same type
    • A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0536—Impedance imaging, e.g. by tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content

Definitions

  • Neuromuscular diseases encompass a large collection of disorders, ranging from relatively mild conditions such as focal compression neuropathies and nerve root injuries (e.g., a capral tunnel syndrome), to severe and life-threatening syndromes, including amyotrophic lateral sclerosis (ALS) and muscular dystrophies. These disorders may lead to muscle atrophy and weakness, caused either by injury to or disease of the neuron (neurogenic disorders), the neuromuscular junction, or the muscle cell itself (myopathic disorders). Another disorder, disuse atrophy, that may occur when a limb is immobilized or a patient is bed-bound for a prolonged period of time, although not classically considered a neuromuscular disorder, also produces substantial morbidity.
  • focal compression neuropathies and nerve root injuries e.g., a capral tunnel syndrome
  • ALS amyotrophic lateral sclerosis
  • muscular dystrophies e.g., ALS
  • ALS amyotrophic lateral sclerosis
  • muscle atrophy and weakness caused either by injury to or disease of the neuron (
  • Neuromuscular diseases have been assessed and diagnosed using various techniques, including nerve condition studies, needle electromyography, muscle imaging, muscle biopsy and genetic testing. However, the initial assessment of the neuromuscular diseases has advanced relatively little beyond conventional needle electromyography and nerve conduction techniques. Similarly, there have been few good approaches to the assessment of disuse atrophy and dysfunction.
  • NCSs Nerve conduction studies
  • EMG needle electromyography
  • NCSs involve stimulation of a nerve with one set of electrodes and recording the resulting muscle or nerve potential with a second set of electrodes.
  • NCSs are of limited use for evaluating muscle disease or disuse states. The stimuli can be uncomfortable and only a relatively limited set of distal muscles in the arms and legs can be evaluated.
  • Needle electromyography is geared more specifically to muscle evaluation. Needle electromyography can provide a quick survey of muscles to determine whether they are being affected by neurogenic injury or myopathic injury.
  • the test has considerable limitations.
  • needle electromyography is very subjective because physicians qualitatively assess the attributes of motor unit action potentials (MUAPs) as they rapidly pass across an oscilloscopic display.
  • MUAPs motor unit action potentials
  • Third, the lack of quantifiable results makes EMG an unsuitable modality for following disease progression/remission.
  • needle EMG remains a somewhat painful, invasive procedure and can thus only be used in a very limited fashion in children.
  • Imaging techniques such as magnetic resonance imaging (MRI) and ultrasound have found some use in muscle atrophy assessment.
  • MRI magnetic resonance imaging
  • ultrasound has found some use in muscle atrophy assessment.
  • MRI magnetic resonance imaging
  • ultrasound has found some use in muscle atrophy assessment.
  • MRI magnetic resonance imaging
  • ultrasound has found some use in muscle atrophy assessment.
  • MRI magnetic resonance imaging
  • ultrasound has found some use in muscle atrophy assessment.
  • MRI magnetic resonance imaging
  • ultrasound has found some use in muscle atrophy assessment.
  • MRI magnetic resonance imaging
  • ultrasound has found some use in muscle atrophy assessment.
  • Muscle biopsy is another test for evaluation of muscle disease and can be helpful in arriving at a specific diagnosis. Muscle biopsy frequently yields limited or contradictory information and may be unsuitable for monitoring progression of atrophy because of its inherent invasiveness. Given that many diseases are patchy (i.e., regions of diseased muscle tissue is interspersed throughout ostensibly healthy muscle tissue), a negative biopsy does not exclude disease, and repeat biopsies sometimes need to be performed.
  • Genetic tests can be very useful for assisting in the evaluation of a number of mostly rare conditions (such as the muscular dystrophies), but is expensive and not relevant to a variety of the most common, acquired conditions.
  • Embodiments of the invention relate to methods and devices for determining a characteristic of a region of tissue by applying an electrical signal to the region and, in response to applying the electrical signal, obtaining an electrical measurement of the region of tissue.
  • Such a technique may be referred to as electrical impedance myography (EIM).
  • One embodiment according to the present invention includes a method of determining at least one characteristic of a region of tissue, the method comprising acts of applying a plurality of first electrical signals to the region of tissue, each of the plurality of first electrical signals being applied at a respective one of a plurality of orientations, obtaining a plurality of measurements from the region of tissue, each of the plurality of measurements indicative of a respective one of a plurality of second electrical signals, each of the plurality of second electrical signals resulting from applying a respective one of the plurality of first electrical signals, and determining the at least one characteristic based, at least in part, on the plurality of measurements.
  • Another embodiment according to the present invention includes a method of determining at least one characteristic of a region of tissue, the method comprising acts of applying a plurality of first electrical signals to the region of tissue, each of the plurality of first electrical signals being applied at a respective one of a plurality of frequencies, obtaining a plurality of measurements from the region of tissue, each of the plurality of measurements indicative of a respective one of a plurality of second electrical signals, each of the plurality of second electrical signals resulting from applying a respective one of the plurality of first electrical signals, and determining the at least one characteristic based, at least in part, on the plurality of measurements.
  • Another embodiment according to the present invention includes a device adapted for application to a surface of skin to determine at least one characteristic of a region of tissue, the device comprising a first electrode adapted to apply a first electrical signal to the region of tissue, a second electrode adapted to detect a second electrical signal at the region of tissue resulting from the application of the first electrical signal, a rotatable base on which the first electrode and the second electrode are mounted and arranged such that, when the rotatable base is rotated, the first electrode and the second electrode are rotated with respect to the region of tissue to apply the first electrical signal to the region of tissue at a plurality of orientations and to detect the second electrical signal resulting from the application of the first electrical signal at the plurality of orientations, and a measurement component coupled to the second electrode to obtain at least one measurement indicative of the second electrical signal at each of the plurality of orientations.
  • Some embodiments according to the present invention are premised on an observation that muscle conducts electrical current preferentially along a direction of its fibers rather than across its fibers.
  • measurement of angular anisotropy in muscle may assist in assessing muscle health and in disease diagnosis.
  • some embodiments according to the present invention provide a system and a device that simplify measurements of the angular anisotropy in muscle tissue.
  • the EIM measurement system may comprise various components.
  • the device may be a hand-held device, also referred to as a probe, which allows obtaining impedance or other measurements of patient's muscle tissues faster and easier.
  • electrodes may be located on a part referred to as a head of the probe.
  • the head of the probe may be of a shape that allows to perform measurements on a patient in a more convenient and efficient matter.
  • the shape of the head of the probe may conform to a curve and shape of a limb or another part of the body.
  • the head of the probe may therefore comprise any suitable curvatures that make the use of the probe more efficient since a closer contact with the scanned surface may be achieved and different areas of the patent's body may be scanned faster and with an improved precision.
  • the probe may comprise a head of a fixed shape, meaning that the head is manufactured to have a permanent shape.
  • the head of the shape may be flexible (via any suitable mechanisms such as spring, etc.) so that the head may conform to the curvature of a scanned surface during application of the probe.
  • the device may employ an array of electrodes designed to allow the device to take impedance measurements at multiple orientations with respect to muscle fibers. Operation of the electrode array may utilize a principle of the linearity of muscle tissue to reduce a required measurement time.
  • the array of electrodes may be located at a head of a probe. In the array, neighboring electrodes may be electrically connected together so that the electrodes may act as a single unit.
  • the array may be of any suitable configuration and arrangement.
  • the array may comprise multiple concentric or otherwise oriented rings.
  • a rectangular electrode array or an array comprising a combination of ring(s) and rows may be employed. Any other suitable configurations of the electrodes may be used as well.
  • the electrodes may comprise vias, pins, solder pads or other suitable electrode elements.
  • the array of the electrodes may be positioned on a head of probe in any suitable manner.
  • the array of the electrodes may be positioned on the head in a manner that allows to obtain measurements efficiently and accurately.
  • the electrode array may be reconfigurable such that the electrodes may be oriented differently with respect to muscle fibers which may reduce a time required to obtain measurements. Applying the electrodes at multiple angles relative to the orientation of muscle fibers may allow obtaining more complete measurements. Also, accuracy and reproducibility of results may be improved because the orientation of the electrodes with respect to the muscle fibers may be altered without physical movement of a head of the probe that bears the electrodes.
  • the device may be used to apply a signal comprising multiple tones which allows measurements of impedance or other parameters at multiple frequencies simultaneously. This may reduce a time required to obtain the measurements.
  • the simultaneous measurement of impedance at multiple frequencies using a reconfigurable electrode array may ensure that EIM measurements are robust, rapidly obtained, and reliable.
  • a method of determining at least one first characteristic of a region of tissue comprises selecting at least one first subset of a first plurality of electrodes to apply a first electrical signal comprising a plurality of frequencies to the region of tissue, detecting at least one value of at least one second characteristic of the region of tissue during a time when the first electrical signal is applied to the region of tissue, selecting at least one second subset of a second plurality of electrodes to detect a second electrical signal at the region of tissue resulting from the application of the first subset, wherein the first plurality of electrodes is reconfigurable to select at least one third subset of the first plurality of electrodes to apply the first electrical signal to the region of tissue and the second plurality of electrodes is reconfigurable to select at least one fourth subset of the second plurality of electrode to detect the second electrical signal at the region of tissue resulting from the application of the third subset, and adjusting the second electrical signal based on the at least one value of the at least one second characteristic.
  • a device for determining muscle condition of a region of tissue may comprise a portable probe which comprises a body, a plurality of electrodes mounted on a base, and at least one sensor.
  • the plurality of electrodes comprise at least one first subset of a first plurality of electrodes adapted to apply a first electrical signal comprising a plurality of frequencies to the region of tissue, and at least one second subset of a second plurality of electrodes to detect a second electrical signal at the region of tissue resulting from the application of the first subset, wherein the first plurality of electrodes is reconfigurable to select at least one third subset of the first plurality of electrodes to apply the first electrical signal to the region of tissue and the second plurality of electrodes is reconfigurable to select at least one fourth subset of the second plurality of electrode to detect the second electrical signal at the region of tissue resulting from the application of the third subset.
  • the portable probe also comprises the at least one sensor that is adapted to obtain at least one first value of at least one characteristic of
  • the EIM probe in accordance with some embodiments of the invention may comprise any suitable devices that may improve efficiency of the probe and accuracy of impedance measurements.
  • the probe may comprise a temperature sensor that allows measuring temperature of a surface of the patient's skin when the probe is applied to the patient's body. Measuring the temperature of the patient's skin may be used to account for variations in the impedance measurements obtained when the probe is applied to the surface of the skin having different temperature.
  • Other suitable devices may be, for example, one or more pressure sensors detecting a pressure with which the EIM probe is applied to the skin of a region of tissue, a moisture sensor to determine moisture content of the skin, an ultrasound sensor, an electrical tomography sensor and any other sensors. The sensor may be incorporated at a head of the EIM probe or otherwise associated with the probe.
  • Embodiments of the invention relate to methods and devices for electrical impedance myography (EIM).
  • EIM electrical impedance myography
  • Neuromuscular disorders can be assessed and diagnosed based on the measured electrical signals.
  • the quantitative nature of the techniques described herein can facilitate the evaluation of the progress of a neuromuscular disorder.
  • the effectiveness of treatments for neuromuscular disorders, such as newly-developed drugs, may be evaluated using the techniques described herein.
  • an electrical signal (e.g., electric current) may be applied to the region of tissue using electrodes applied to the skin.
  • Various characteristics can be determined based on the electrical parameters that are measured for the region, such as the impedance, reactance, resistance and/or phase shift.
  • EIM may be more rapid, more quantitative, less invasive and more repeatable. EIM can be used for the assessment of muscle conditions, and more specifically, neuromuscular disease.
  • EIM is not limited to the assessment of neuromuscular disease, as any other suitable tissue characteristic(s) may be measured using EIM, such as the amount of muscle atrophy that has occurred through disuse of a muscle (or more rarely, hypertrophy), as the aspects of the invention are not limited in this respect.
  • Some embodiments of the invention relate to methods and devices for performing multi-frequency EIM, which involves performing EIM using at least two different frequencies of electrical signals. Because the electrical parameters of a muscle can be dependent on the frequency of an alternating current applied to a muscle, measurements of the muscle impedance for a plurality of frequencies can be utilized to facilitate diagnosis of muscle condition, and to differentiate between normal and abnormal muscle tissue. Multi-frequency EIM can be performed by varying the frequency of the alternating current applied to the muscle or group of muscles. For example, the frequency that is applied may be in the range between about 2 kHz and about 2 MHz, but the invention is not limited to this particular frequency range, as any other suitable frequency range can be used.
  • a multi-frequency signal may be used to achieve rapid data acquisition at multiple frequencies simultaneously.
  • the multi-frequency signal may be used.
  • the applied signal may be, for example, of frequencies between 10 kHz and 4 MHz. However, it should be appreciated that the invention is not limited to this particular frequency range, as any other suitable frequency range can be used. Thus, in some embodiments, the applied signal may be of a frequency lower than 10 kHz. Signals of frequencies higher than 4 MHz may also be applied.
  • the alternating current can be injected via one set of surface electrodes (referred to as current-injecting electrodes), and the resulting voltage patterns can be recorded via a second set of surface electrodes (referred to as voltage-recording electrodes).
  • an impedance instrument can convert the voltage signals into a resistance (R) and reactance (X), for each applied frequency. From these parameters, a phase ( ⁇ ) may be computed, for each applied frequency.
  • R resistance
  • X reactance
  • ⁇ phase
  • any suitable electrical parameters may be measured and/or calculated for evaluation of muscle tissue, as the invention is not limited in this respect.
  • the current-injecting and voltage-recording electrode may form an array of electrodes that may be configured to adopt different configurations at which the array operates as a single composite electrode.
  • each set of the electrodes may be arranged into a ring, with different sets of electrodes forming multiple concentric ring configurations. Any suitable number of rings, as well as other geometric configurations, may be used in the electrode array as embodiments of the invention are not limited in this respect.
  • excitation electrodes may be selected from electrode elements that form an outer ring, while pickup electrodes may be selected from electrode elements that form two inner rings. Though, any other suitable combinations of electrodes may be implemented. Thus, in some embodiments, additional electrodes may be utilized, which may improve reproducibility of the impedance measurements.
  • additional excitation and pickup electrodes may be employed to evaluate a depth of a skin-subcutaneous fat layer, which may be used to account for effects of impedance at different depths of this layer on the impedance measurements of the muscle tissue.
  • rings formed of multiple electrodes
  • rings with smaller radii e.g., the innermost rings of a plurality of concentric rings
  • Rings with larger radii e.g., the outermost rings of the plurality of concentric rings that include the innermost rings with the smaller radii
  • changes in muscle condition e.g., a progression of a disease
  • changes in muscle condition may be detected using different sets of excitation and pickup electrodes.
  • impedance measurements obtained using one set of electrodes e.g., forming the outermost rings
  • impedance measurements obtained using other set of electrodes e.g., forming the innermost rings
  • Other suitable combinations of the sets of electrodes may also be utilized.
  • functions of the excitation and pickup electrodes may be interchangeable.
  • each of the individual electrodes or a group of electrodes may be programmed to operate as either excitation or pickup electrodes.
  • Some embodiments of the invention relate to a method and apparatus for performing multidirectional EIM (also referred to as rotational EIM). Because the measured electrical parameters of a muscle can be anisotropic, and therefore dependent on the orientation of the measurement electrodes relative to the muscle fibers, electrical parameter measurements in a plurality of different directions can be utilized to facilitate diagnosis of muscle condition, and to differentiate between normal and abnormal muscle tissue.
  • multidirectional EIM also referred to as rotational EIM
  • a method and apparatus is provided for both multi-frequency and multidirectional EIM. Such combined measurements can provide more diagnostic information than multi-frequency or multidirectional EIM alone.
  • a method and apparatus is provided for performing EIM during contraction of a muscle, referred to as dynamic EIM. The contraction can be voluntary or electrically induced.
  • the EIM probe may be used to obtain impedance measurements during alternating contraction and relaxation of the underlying muscle or muscle group(s). In such scenarios, any suitable combination of contraction and relaxation of the muscles may be employed. Changes in impedance measurements with contraction of the muscles may provide useful data that may be indicative of neuromuscular abnormalities of the muscles. Such data may thus be used to differentiate between normal and diseased and to identify a type of a disease.
  • the EIM probe may be supplemented with a suitable device (e.g., a force transducer) to measure the muscle contraction. Hence, simultaneous measurements of impedance and contraction force of the muscle may be obtained.
  • electrical nerve stimulation may be implemented to assess various properties of the muscle.
  • a combination of multi-frequency, multidirectional, and/or dynamic EIM measurements can also be used to differentiate between different types of abnormal muscle conditions, including neuromuscular conditions (e.g., amyotrophic lateral sclerosis (ALS), inflammatory myopathy) and neurogenic conditions.
  • neuromuscular conditions e.g., amyotrophic lateral sclerosis (ALS), inflammatory myopathy
  • a stage of a disease may be assessed as well.
  • any of the aforementioned embodiments can be performed on one or more muscles including quadriceps, biceps, tibialis anterior, etc., as the invention is not limited to any specific muscle or muscle group.
  • a method and apparatus are provided for use of a composite signal comprising multiple tones that makes possible measurements of impedance of muscle tissue at multiple frequencies simultaneously. This may reduce a time required to obtain the measurements.
  • an EIM measurement system may be provided that allows taking impedance measurements at multiple orientations with respect to muscle fibers by using an electrode array which may be reconfigurable.
  • such system may comprise a portable probe with a head bearing an electrode array having electrodes elements arranged in any suitable manner.
  • the electrode array may be reconfigurable (e.g., electronically) such that the electrodes may be oriented differently with respect to muscle fibers which may reduce a time required to obtain measurements. More complete measurements may be obtained by applying the electrodes at multiple angles relative to the orientation of muscle fibers.
  • accuracy, speed and reproducibility of results may be improved because the orientation of the electrodes with respect to the muscle fibers may be altered without physical movement of the head of the probe.
  • simultaneous measurement of impedance at multiple frequencies using a reconfigurable electrode array may ensure that EIM measurements are robust, rapidly obtained, and reliable.
  • the user-friendliness and convenience of use of the portable device for EIM measurements makes it an attractive tool for use in various settings. For example, the patient may not need to be moved to conduct measurements because the device may be brought to a location of the patient, which may be particularly useful for diagnosing and monitoring neuromuscular diseases in bedridden patients.
  • the EIM measurement system may allow, in addition to obtaining impedance measurements, to obtain measurements of different additional parameters to thus improve efficiency of the system and increase accuracy of assessment and/or diagnosis of a muscle condition. These additional measurements may be collected as part of monitoring of different factors that may affect the quality of the impedance measurements.
  • the EIM system may comprise one or more suitable devices (e.g., suitable sensors) to obtain the measurements of the additional parameters.
  • the devices may be associated with an EIM probe in any suitable manner. For example, one or more devices may be incorporated in a suitable location at a head of the EIM probe.
  • the additional parameters may provide information on the patient's skin conditions, quality of EIM measurements being obtained and other factors.
  • the additional devices may be used to obtain measurements of such parameters as, for example, a temperature of the skin in the region to which the EIM probe is applied, the moisture content of the skin in this region and pressure with which the EIM probe is applied.
  • measurements of electrode contact quality reflecting how closely the electrodes of the electrode array of the EIM probe contact the skin of the region being analyzed may be obtained.
  • any other suitable parameters may be obtained in addition to impedance measurements obtained using the EIM probe.
  • the EIM measurement system may comprise one or more suitable sensors to measure a temperature of the skin to which the EIM probe is applied. Variations in the skin and tissue (i.e. muscle) temperature may affect impedance measurements. Accordingly, temperature of the limbs or other parts of the patient's body can be adjusted to a specific temperature (e.g., 34 C°), which may be inconvenient and cumbersome. Accordingly, including a temperature sensor, such as a thermocouple or other suitable device, within the EIM probe may allow performing measurement of the skin temperature simultaneously with the impedance measurements.
  • a temperature sensor such as a thermocouple or other suitable device
  • One or more of suitable temperature sensors may be placed in any suitable location in proximity to the electrode array of the EIM probe. Thus, in some embodiments, the temperature sensor may be placed in the center of the electrode array. Though, it should be appreciated that embodiments of the invention are not limited in this respect and temperature sensor may be placed in any suitable location within or near the electrode array.
  • the impedance measurements may be adjusted in accordance with variations in the temperature of the skin that may occur during taking EIM measurements.
  • an automatic adjustment (or correction) for the variations in the temperature may be performed so that EIM measurements are presented to a user as adjusted, or corrected, values for the variations in the temperature of the skin of the patient.
  • Such adjustment may result in an improved accuracy of the impedance measurements. Also, this may improve an accuracy and reliability of comparison of impedance measurements obtained from a region of a patient's body at different periods of time.
  • the EIM measurement system may be used to obtain electrode contact quality measurements indicative of how closely the electrodes of the electrode array of the EIM probe contact the skin of the region where the EIM probe is applied.
  • one or more electrodes of the electrode array may not contact the surface of the patient's skin where the EIM probe is applied sufficiently well to obtain impedance measurements with good resolution.
  • the EIM probe may be applied such that the electrodes are positioned at a distance from the surface of the skin that is larger than a predetermined distance at which impedance measurements with good resolution may be obtained. This may occur due to various conditions related to characteristics of the patient's skin. For example, the skin may be dry, callused, injured or abnormal in any other manner that compromises effective electrical transmission and measurement via the electrode array. Other factors may affect quality of the electrode contact as well.
  • a head of the probe bearing the electrode array may not contact the surface of the skin evenly so that one or more of the electrodes of the electrode array may not be in contact with the surface of the limb curve. In some circumstances, reliable impedance measurements may not be obtained at all.
  • the EIM measurement system may measure electrode contact quality reflecting how closely each of the electrodes of the electrode array of the EIM probe contacts the skin of the region being analyzed.
  • the electrode contact quality may be measured as a degree of contact between an electrode and a surface of the region being analyzed. The degree of contact may then be compared to a predetermined threshold.
  • Any suitable components and techniques may be used to measure the electrode contact quality.
  • suitable characteristics of the skin in a region to which the EIM probe is applied may be measured.
  • the electrode contact quality measurements may include measuring the moisture content of the skin.
  • Any suitable device, such as a hydrometer may be used to measure the moisture content of the skin.
  • the impedance measurements obtained using the electrodes array may be used to determine the electrode contact quality.
  • the EIM system may generate a signal or other indication indicating that a degree of contact of one or more electrodes of the electrode array does not meet requirements of a degree of contact for obtaining EIM measurements of good quality.
  • the one or more electrodes may not contact the skin of the region being analyzed sufficiently closely. Any suitable measure of what constitutes a "sufficiently close" contact may be employed.
  • a threshold degree of contact may be selected to be compared with the measured degree of contact.
  • the signal may inform a user of the EIM probe performing the impedance measurements of such "faulty" electrodes.
  • the signal may comprise an audio signal, such as an alarm.
  • a signal of any suitable format may be substituted. Also, other type of example,
  • a suitable correction for the presence of the "faulty" electrodes may then be implemented.
  • the correction may be implemented automatically, by reconfiguring the electrode array in response to the detection of one or more electrodes of the electrode array that does not contact the skin sufficiently closely, so that the "faulty" electrode of the electrode array is excluded from a group of electrodes used to obtain the impedance measurements.
  • the electrode contact quality measurements may be continuous or via time intervals, and, if it is detected that the "faulty" electrode comes to contact with the skin, this electrodes may be used in the impedance measurements.
  • the EIM measurement system may, in addition to obtaining impedance measurements, monitor force with which the EIM probe is being applied to a region of tissue.
  • the force may be monitored using any suitable device.
  • one or more pressure sensors may be employed.
  • the pressure sensor may be embedded into or otherwise associated with the EIM measurement system in any suitable manner (e.g., located within the EIM probe) and may be any suitable device.
  • the pressure sensor may provide, during a time when the EIM probe is applied to the patient's body, an indication to a user of the EIM probe of a value of the force being applied, including an indication of whether an inadequate, adequate, or excessive force is being applied.
  • more than one pressure sensors may be used to ensure that the pressure is being applied equally to entire surface of the electrode array of the EIM probe.
  • the impedance measurements may be adjusted for variations in force with which the EIM is applied to a region of tissue of the patient.
  • the EIM measurement system may be associated with any other suitable devices that may enhance reliable detection of muscle condition.
  • electrical impedance tomography techniques may be used in addition to EIM measurements.
  • the electrical impedance tomography may provide insights into further characterization of muscle conditions and may help to discern the structure of the muscle.
  • the ultrasound measurements may provide information on variations in orientation and/or thickness of the skin-subcutaneous fat layer. This information may then be utilized to adjust the impedance measurements for these variations.
  • the results of the ultrasound measurements may be combined in a suitable manner with the EIM measurements to provide a more complete analysis of the underlying tissue.
  • a suitable ultrasound measurement device may be embedded into or otherwise associated with the EIM probe. The ultrasound measurement device may be configured to automatically asses the orientation and/or thickness of the skin-subcutaneous fat layer.
  • electrodes in an electrode array of the EIM probe may form different patterns, a nonlimiting example of which includes multiple concentric rings.
  • the electrode array may also be of different sizes so that smaller arrays may be used for assessment of conditions of smaller muscles or muscles of children.
  • the electrodes may be fixedly attached to a base such as a printed circuit board or other suitable base.
  • the base may be rotatable.
  • the electrode array may be designed to be disposable, meaning that the electrode array may be attached to the body of the EIM probe so that the array may be easily removed. Such electrode array may be referred to a disposable electrode array.
  • the EIM probe may be used with different electrode arrays.
  • the disposable electrode array may be manufactured to be sterile, which may help lower a rink of spreading of infections (e.g., bacterial infections such as those caused by Staphylococcus aureus ) between patients.
  • the probe When the EIM probe is adapted to bear a disposable electrode array, the probe may be equipped with a mechanism for easy attachment and removal of the array from the probe (e.g., a head of the probe).
  • the backing of the electrode array may be made of a firm plastic and the electrodes may be made from different other materials.
  • the electrode array may be then clipped onto the EIM probe via a suitable locking mechanism and then disposed of via a suitable release mechanism when EIM measurements are completed.
  • FIG. 1 illustrates an example of an apparatus 100 that may be used to perform multi-frequency EIM, according to one embodiment of the invention.
  • Apparatus 100 includes electrodes 112-115, and also circuit 102 that measures and generates electrical signals using signal measurement circuit 104 and signal generation circuit 106.
  • Apparatus 100 may include any components in any arrangement capable of delivering electrical signals and measuring electrical signals resulting from the electrical signals delivered, as the aspects of the invention are not limited in this respect.
  • signal generating circuit 106 is coupled to two spaced-apart current-injecting electrodes 112 and 113, which may be applied to region of tissue 108.
  • electrodes 112 and 113 an electrical signal is applied to region of tissue 108, for example, by passing an electrical current through the skin and into the region of tissue.
  • the electrical signal that is applied may be any suitable signal, such as a predetermined voltage potential or a predetermined current.
  • the electrodes may be isolated from a supply voltage using a transformer or any suitable device, such that a "floating" signal, and applied to the patient, thus enhancing the safety of the procedure.
  • the signal that is applied to current-injecting electrodes 112 and 113 may be a sinusoidally varying voltage having a magnitude of approximately 1 volt (peak-to-peak) and a frequency between 2 kilohertz and 2 megahertz. As a consequence of applying this signal, electric current is injected into region of tissue 108.
  • these values of voltage, shape and frequency are provided merely by way of illustration, as the invention is not limited in these respects.
  • any suitable circuit and/or technique may be used to generate the electrical signal applied to the region of tissue, as the aspects of the invention are not limited for use with any particular method of electrical signal generation and/or application.
  • Signal measuring circuit 104 is coupled to two spaced-apart voltage-measuring electrodes 114 and 115. While the generated signal is applied to tissue region 108 by signal generation circuit 106, signal measurement circuit 104 measures a signal at the tissue region using voltage-measuring electrodes 114 and 115. The signal that is measured may be a voltage difference between the two electrodes that results from the generated signal. Any suitable circuit and/or technique may be used to measure the signal, as the aspects of the invention are not limited in this respect.
  • Circuit 102 may analyze the measured signal and determine a characteristic of the region of tissue based on the measured signal. Any suitable property of the signal may be measured, such as the magnitude, phase, impedance, resistance and reactance or any suitable combination thereof. In some embodiments of the invention, the measured voltage difference at electrodes 114 and 115 may be divided by the current applied through electrodes 112 and 113 to obtain an impedance measurement. Circuit 102 may determine an impedance, resistance, reactance, phase and/or any other suitable property of the region. Based on the measured signal, any of suitable electrical parameters, and/or electrical properties of the region of tissue, circuit 102 may determine a muscle characteristic. For example, circuit 102 may diagnose and/or assess a neuromuscular disease based on any suitable criteria, as discussed in further detail below.
  • circuit 102 may display one or more of the determined electrical parameters to facilitate diagnosis and/or assessment by a physician or technician.
  • Circuit 102 may include any suitable components for performing such measurements, calculations, determinations and presentation functions.
  • circuit 102 may include a lock-in amplifier for impedance measurement, a computer for performing calculations and a display for displaying the results to a human (e.g., a technician or a physician).
  • a human e.g., a technician or a physician.
  • any suitable components or combination of components may be used, as the invention is not limited for use with any particular components or configuration of the components.
  • FIG. 2 is a flowchart of a method 200 for performing multi-frequency EIM, according to one embodiment of the invention.
  • a first signal of a first frequency is applied to a tissue region in step 202, and a first signal measurement is made in step 204, such that the measured signal is a result of applying the first signal of the first frequency.
  • a second signal of a second frequency is applied to the tissue region in step 202, and a second signal measurement is made for the second frequency in step 204.
  • Further signals at different frequencies may also be applied, and corresponding measurements may be taken.
  • Any suitable number of frequencies may be used in the multi-frequency EIM procedure, as the invention is not limited as to the number of frequencies measured or the exact frequencies at which measurements are taken.
  • the frequencies used should be of a number and value such that the measurements are sufficient to provide information useful in assessment or diagnosis of the tissue region, e.g., the assessment or diagnosis of a muscle condition.
  • a characteristic of the region of tissue is determined based on the measurements.
  • the characteristic that is determined may be a muscle characteristic, and may be determined based on one or more electrical properties obtained from the measurements, such as the impedance, phase, resistance and/or reactance of the muscle.
  • a frequency-averaged impedance, phase, resistance and or reactance may be determined for at least a portion of the range of frequency measurement.
  • the frequency-averaged parameter may be a useful parameter for comparing healthy vs. unhealthy tissue, and evaluating changes in the tissue over time. For example, a diagnosis of a neuromuscular condition may be made based on a frequency-averaged parameter being above or below a threshold value.
  • One or more electrical properties obtained from measurements taken from the region of tissue as a function of frequency may be used as a signature for the region of tissue.
  • signature refers herein to any collection of information obtained from a region of tissue that is characteristic of the tissue.
  • the signature of the tissue, once obtained, may be analyzed to assess, diagnose or otherwise determine a characteristic and/or condition of the region of tissue.
  • the signature of the tissue may be computationally processed and/or analyzed or presented to a physician or technician for analysis.
  • a plot of an electrical parameter vs. frequency e.g., resistance, reactance or phase of the tissue vs. frequency
  • a physician may make a diagnosis based on the plot displayed.
  • Multiple plots displaying any of various electrical properties of the tissue with respect to frequency may be displayed, as the aspects of the invention are not limited in this respect.
  • FIGS. 3A-C show plots of resistance, reactance and phase vs. the logarithm of frequency, respectively, measured for two different ALS patients (C and J) at two different visits, 3-4 months apart each.
  • the solid line shows the measurements taken at the first visits and the dashed lines shows the measurements taken at the follow-up visits.
  • Patient C had relatively mild ALS
  • patient J had a more severe form of the disease.
  • FIGS. 3B-C the patient (J) with the more severe muscle disorder had lower phase and reactance values than the patient (C) with the less severe disorder.
  • both patients exhibited primarily a decrease in both phase and reactance measured, which illustrates the progression of the disease over time.
  • circuit 102 may be configured to analyze the signature (e.g., one or more electrical properties as a function of frequency) to determine a characteristic of the region of tissue and/or to assess a condition of the region of tissue.
  • signature e.g., one or more electrical properties as a function of frequency
  • multidirectional (or rotational) EIM may be used for the assessment and characterization of a region of tissue.
  • Multidirectional EIM can be performed by measuring the voltage difference between voltage-measuring electrodes that are arranged with a desired orientation with respect to an axis of the muscle fibers. Both the current-injecting electrodes and the voltage-recording electrodes may have the same orientation with respect to the muscle fibers.
  • the electrical properties of the region of tissue at various orientations may be used to characterize the region of tissue, e.g., to assess a condition of the muscle and/or to perform a diagnosis of the muscle.
  • FIGS. 4A-B are diagrams illustrating performing EIM at different orientations with respect to a region of tissue 108.
  • FIGS. 4A-B show electrodes 112-115, as described above with respect to FIG. 1 .
  • Electrodes 112-115 may be mounted on a base 402.
  • FIG. 4A illustrates performing EIM along a direction A-A aligned with an axis of the region of tissue 108, e.g., substantially aligned with fibers of the muscle.
  • FIG. 4B illustrates performing EIM along a direction at an angle ⁇ with respect to the axis.
  • Measurements obtained at the different orientations may be used to characterize and/or otherwise assess a condition of the region of tissue 108. Measurements may be obtained at multiple orientations to obtain information about how properties of the tissue vary with orientation (e.g., to determine a degree of anisotropy of the tissue), as discussed in further detail below.
  • electrodes 112-115 are mounted on rotatable base 402, which is made of electrically insulating material. When a measurement is to be taken, electrodes 112-115 are brought into contact with the skin at the region of tissue, and are aligned in a first direction with respect to an axis of the region. When a second measurement is to be taken, base 402 is rotated by the desired angle ⁇ , and electrodes 112-115 are again brought into contact with the skin at the new orientation.
  • measurements may be made at different angles.
  • measurements may be made at six different angles, each 30° apart (0°, 30°, 60°, 90°, 120° and 150°).
  • any suitable angle increments or number of measurements at different angles may be used, as the invention is not limited in this respect.
  • the angles used should be of a number and increment such that the measurements are sufficient to provide information useful in assessment or diagnosis of the tissue region, e.g., the assessment or diagnosis of a muscle condition.
  • electrodes 112-115 may be mounted on rotatable base 402 made of an electrically conductive material.
  • the electrically conductive base 402 may be brought into contact with the skin at the region of measurement, and the electrodes themselves may not contact the region directly.
  • electrically conductive base 402 may be anisotropically conductive such that it preferentially conducts current in a direction perpendicular to the base (e.g., into the patient's body). The anisotropy of the conductive base can prevent undesirable cross-talk between the electrodes, and may allow current to penetrate a greater depth into the tissue region.
  • FIG. 5 illustrates another embodiment using rotational EIM, in which a plurality of current-injecting electrodes 502 and voltage-measuring electrodes 504 are mounted on base 402 at different orientations. Since the electrodes are mounted at a plurality of different orientations, it may not be necessary to rotate the electrodes or base 402 to make measurements at different angles.
  • an appropriate pair of current-injecting electrodes can be selected and coupled to signal-generating circuit 106 using any suitable switches. That is, the plurality of electrodes may be configured such that the combination of electrodes 502 and 504 at any desired orientation may be selectively activated.
  • the current-injecting electrodes that lie along line 506 may be selected first.
  • the appropriate pair of voltage measuring electrodes 504 that lie along line 506 may be selected, and may be coupled to signal-measuring circuit 104 using any suitable switches.
  • a first measurement may then be taken along direction 506.
  • the switches may be reconfigured to couple different electrodes 502 and 504 to the appropriate circuits, and measurement may be taken at a different orientation.
  • FIG. 6 illustrates an example of a hand-held apparatus 600 that may be used for performing EIM, including rotational and/or multi-frequency EIM.
  • Providing a hand-held EIM device may facilitate making EIM measurements, and thus may reduce the amount of time needed to make the measurements.
  • Hand-held apparatus 600 may include a handle 602, a user interface 604, a body 606, base 608 and electrodes 112-115.
  • the electrodes may be coupled to circuit 102 in any suitable way, such as through a cord attached at the bottom of handle 602, for example.
  • FIG. 6 illustrates direction A-A corresponding to direction A-A illustrated in FIG. 4A .
  • base 608 may be rotatable, as discussed above, for performing rotational EIM.
  • base 608 may not be rotatable, but may have a plurality of electrodes 502 and 504 positioned at different orientations, as described in connection with FIG. 5 .
  • Apparatus 600 may be configured such that either technique may be used, depending on the type of base/electrode combination that is mounted to the apparatus. In some circumstances, it may be desirable to provide multiple different base/electrode combinations of different sizes that may be easily interchangeable for measuring different types of muscles, or muscles of different sizes. When a different size is needed, the base 608 may be detached from apparatus 600 and another base may be attached.
  • FIG. 7 is a flow chart of a method 700 of performing rotational EIM, according to one embodiment of the invention.
  • a first signal is applied to a tissue region at a first orientation
  • a second signal resulting from the first applied signal
  • a third signal is applied to the tissue region at a different orientation.
  • a linear electrode array may be rotated, and another measurement may be made, as illustrated in FIGS. 4A-B .
  • a quasi-circular electrode array is used ( FIG. 5 )
  • a different set of electrodes may be selected that correspond to a different orientation, and a corresponding measurement may be made. It is preferred that at least one measurement be made along a muscle axis, and that at least one measurement be made perpendicular to the muscle axis.
  • a tissue characteristic is determined based on the measurements, using any suitable criteria as discussed above.
  • the one or more electrical properties obtained as a function of orientation may be used as a signature of the region of tissue.
  • this signature may be analyzed to determine a characteristic of the tissue and/or to assess a condition of the muscle. For example, how the one or more electrical properties vary with orientation (e.g., a degree of anisotropy) may be used to assess the health of the tissue and/or diagnose a condition such as a specific neuromuscular disorder.
  • the signature may be analyzed quantitatively, or compared to a reference signature obtained from known healthy or diseased tissue to assist in the analysis and/or diagnosis of the tissue.
  • FIGS. 8A-C show plots of resistance, reactance and phase vs. angular orientation, respectively, for both control patients and an ALS patient.
  • the measured electrical parameters depend on the orientation of the measurement with respect to an axis of the muscle fibers, with 0° being aligned with the axis.
  • the reactance and phase were lower for the patient with ALS than for the control patients.
  • the control measurements exhibited more significant peaks at 90° in both reactance and phase for the control patients than for the patient with ALS.
  • the frequency dependence and orientation dependence of one or more electrical properties of a region of tissue are both exploited to obtain a signature of the region of tissue. For example, at each of a plurality of orientations, an electrical signal may be applied at a plurality of frequencies. Measurements of the tissue may be taken for each frequency at each orientation to determine one or more electrical properties of the tissue at the various frequencies and orientations. By obtaining information about both frequency and orientation dependence, a richer set of indicators may be available to facilitate determining a muscle characteristic and/or assessing a condition of the tissue.
  • FIG. 9 shows a three-dimensional plot 900 illustrating the results of performing both multi-frequency and rotational EIM.
  • the control patient exhibited higher phase measurements and more pronounced phase peaks with respect to both frequency and orientation, as compared to a patient with ALS.
  • multi-frequency and rotational EIM can be useful, either alone or in combination, for assessing and detecting neuromuscular disorders.
  • the quantitative nature of the measurements may allow for more accurate assessment and diagnoses of neuromuscular disorders, and also the evaluation of therapies for muscle disorders.
  • a design of the EIM measurement system may be based on a tetrapolar measurement setup known to be used in impedance measurements in biological systems, which is schematically illustrated in FIG. 10 .
  • impedance measurements may be taken by using a set of, for example, four electrodes arranged parallel to each other. It should however be appreciated that any suitable number of electrodes may be used.
  • dashed lines illustrate equipotential lines and solid lines illustrate current flow lines. The shaded region represents a high-resistivity skin-fat layer.
  • two outer electrodes 1002 and 1004 which may be referred to as current-injecting, or excitation electrodes, provide an input signal to a tissue being investigated. This creates an electric potential distribution that may be measured by two inner voltage-recording, or pickup electrodes 1006 and 1008.
  • the tetrapolar measurement system may allow obtaining improved measurements that are uncorrupted by a contact resistance between the probes and the skin.
  • the EIM measurement system may comprise, as shown schematically in a system 1100 in FIG. 11 , a signal generator 1102, a crosspoint switch network 1104, an electrode array 1106, which may be reconfigurable, and a data acquisition module 1108.
  • Electrode array 1106 may be reconfigurable electronically, manually, or in any other suitable manner.
  • System 1100 may comprise any other suitable components as well, as discussed in more detail below. Electrodes of the electrode array may be located on a head of a portable device. In the array, neighboring electrode elements (e.
  • a composite electrode may act a single unit which may be used for signal excitation or pickup.
  • a signal comprising multiple frequencies may be applied to muscle tissue.
  • the excitation (e.g., current-injecting) electrodes and pick-up (e.g., voltage-measuring electrodes) of the electrode array may be reconfigurable automatically.
  • the electrodes that provide sufficiently high resolution of measurements of the muscle anisotropy may be selected automatically.
  • the electrode array may be reconfigured so that these "faulty" electrodes are not used in the impedance measurements.
  • an excitation signal may be a composite signal comprising multiple tones with logarithmically spaced frequencies.
  • the frequencies may be, for example, from 10 kHz to 4 MHz. Though, it should be appreciated that the frequencies may be lower than 10 kHz or higher than 4 MHz as embodiments of the invention are not limited in this respect. Applying the composite signal may allow obtaining impedance or other measurements easier and faster.
  • a waveform for this composite signal may be first synthesized (e.g., using MATLAB®, a product of the Mathworks, Inc.) and then downloaded to an arbitrary waveform generator (AWG) such as, for example, Tektronix AFG 3102 AWG.
  • a differential voltage driver may be used to convert the single-ended signal output from the AWG to a differential signal and also to ensure that an amplitude of the differential signal is safe for clinical use.
  • the excitation signal may be applied to a patient's skin via an electrode array.
  • the array may be fabricated, for example, on a printed circuit board. In the system shown in FIG. 12 , vias on a printed circuit board may act as electrodes for the EIM measurement system.
  • the array of the electrodes may be reconfigurable.
  • both a size and a position of the excitation and pickup electrodes may be reconfigured on-the-fly using a crosspoint switch network or any other suitable component(s).
  • Electrical impedance measurements as a function of angle and frequency may be obtained using the arrangement shown in FIG. 12 .
  • a Tektronix TDS 3034B oscilloscope sampling at 10MS/s may be used as an analog-to-digital converter employed to digitize the measured voltages for further processing on a computer.
  • the computer may be, for example, a notebook computer.
  • any suitable computing device may be used to process measured voltages.
  • a use of a mobile computing device allows making the EIM measurement system portable. Mechanically, the EIM measurement system may be designed to fit in the hand of a clinician or any other user so that impedance or other suitable measurements of patient's muscles may be conveniently made at a variety of positions.
  • the electrode array is shown as a rectangular array by way of example only. It should be appreciated that the electrode array may be of any suitable configuration. Thus, as shown in a photograph on FIG. 13 , electrodes located on a head, or an electrode head, of a probe may also be distributed in three concentric rings. Any suitable number of rings, as well as other geometric configurations, may also be used in the electrode array in accordance with various aspects of the invention.
  • excitation electrodes may be selected from electrode elements that form an outer ring, while pickup electrodes may be selected from electrode elements that form two inner rings.
  • the electrode selection may be accomplished using a crosspoint switch network, as shown in FIGs. 11 and 12 .
  • ADG2128 Analog Devices, Inc., Norwood, MA
  • crosspoint switches may be employed. These components may enable any combination of electrodes to be connected to both the excitation outputs and the detection inputs. Reproducible results may be obtained because the orientation of the composite electrodes with respect to muscle fibers can be altered without physical movement of the electrode head.
  • the crosspoint switches may be controlled by a computer (e.g., a notebook computer) via, for example, a USB interface.
  • a computer e.g., a notebook computer
  • Suitable software may be executed by a processor of the computer to control the crosspoint switches.
  • the software may be custom designed software.
  • FIG. 14 illustrates another example of the EIM measurement system 1100 according to one embodiment of the invention.
  • measurement and signal generation components comprise portable USB powered components.
  • An excitation signal may be a composite signal comprising multiple tones.
  • the signal may be a composite signal comprising multiple tones with 20 logarithmically spaced frequencies from 10kHz to 300kHz.
  • a waveform for this signal may be first synthesized using MATLAB® and then downloaded to a USB powered Handyscope such as Handyscope HS3 (TiePie Engineering, the Netherlands) which has a built-in AWG.
  • a differential voltage driver shown as “signal conditioner,” may convert the single-ended signal output from the Handyscope HS3 AWG to a differential signal and may also ensure that the amplitude of the differential signal (e.g., less than 5mA) is safe for clinical use.
  • the excitation signal from the differential voltage driver may be applied to a patient's skin via an electrode array fabricated on a printed circuit board.
  • each electrode array element may be a solder pad that is electrically connected to one of the input/output pins of crosspoint switches of a crosspoint switch network.
  • the crosspoint switch network may comprise, for example, ADG2128 crosspoint switches.
  • a size and a position of the composite excitation and pickup electrodes may be reconfigured using, for example, I 2 C commands sent to the crosspoint switch network by a MSP430 microcontroller (Texas Instruments, Inc., Dallas, TX) or by any other suitable controller. The reconfiguration may occur on-the-fly, while the probe is used to obtain measurements from a patient.
  • USB powered oscilloscope such as, for example, Handyscope HS4 oscilloscope with four input channels sampling at 50MS/s may be used as an analog-to-digital converter used to digitize the measured voltages for further processing on a computing device such as, for example, a portable computer. Any other suitable component may be used for this purpose as well.
  • FIG. 15 is a photograph of the EIM measurement system shown schematically in FIG. 14 . All of the components of the system shown in FIG. 15 may be powered by a portable power source such as, for example, a battery, a USB power source or any other suitable power source.
  • a portable power source such as, for example, a battery, a USB power source or any other suitable power source.
  • the system may be used as a portable EIM measurements system, with the EIM probe being transferred to a location of a patient or to any other location. This make the system more use-friendly.
  • FIG. 16 A photograph of an example of a probe having a reconfigurable electrode head is shown in FIG. 16 . This photograph demonstrates that the probe may be powered by a portable power source such as a battery or a USB power source.
  • a portable power source such as a battery or a USB power source.
  • neighboring electrode elements of an electrode array may be connected together to create a so-called composite electrode.
  • the electrode elements of such composite electrode may act as a single unit which can be used for signal excitation or pickup.
  • An example design of an electrode array arranged on a head of the EIM probe illustrated in connection with FIGs. 14 and 15 is shown in FIG. 17 .
  • FIG. 17 two possible patterns of electrode elements that may be created are illustrated.
  • four composite electrodes that may be created to make an input signal current to flow along a major muscle fiber direction are highlighted with solid lines.
  • the old pattern is cleared and a new one is created. This new pattern is shown with dashed lines.
  • both single solid electrodes and electrodes composing an array may be made, for example, from Ag-AgCl.
  • the plots in FIG. 18 demonstrate that impedance measurements taken by the portable EIM system are comparable to those taken by EIM systems in which solid electrodes are used.
  • electrode elements of the EIM system may comprise solder pads on, for example, a printed circuit board.
  • the electrode elements may be distributed as two concentric rings.
  • excitation electrodes may be selected from an outer ring and pickup electrodes may be selected from an inner ring.
  • Electrode selection may be performed using, for example, four ADG2128 crosspoint switches (Analog Devices, Norwood, MA). Each electrode element may be connected to one of the input/output pins of the ADG2128 crosspoint switches labeled from XI - X12 in FIG. 20 .
  • Systems comprising components shown on FIGs. 14-16 and 19 may enable any combination of electrode elements to be connected to both the excitation outputs (e.g., a differential voltage driver) and the detection inputs (e.g., Handyscope HS4 oscilloscope).
  • Commands required to control operation of the crosspoint switches may be provided by a MSP430 microcontroller (Texas Instruments, Inc., Dallas, TX) over an I 2 C serial interface.
  • the MSP430 microcontroller may run a firmware (e.g., written in the C programming language) that translates commands from a graphical user interface (GUI) provided by the notebook computer into the I 2 C commands for the ADG2128 crosspoint switches. Using these I 2 C commands, any pattern of electrode elements may be created.
  • GUI graphical user interface
  • FIG. 18 shows a photograph of an example of chip components used in the reconfigurable electrode head mounted on a custom designed printed circuit board.
  • An EIM measurement system comprising components shown on FIGs. 14-16 and 19 may allow obtaining reproducible measurement results because orientation of the composite electrodes with respect to the muscle fibers may be altered without physical movement of the electrode head. This may make it possible to accurately alter the direction of current propagation and improve the angular resolution of measurements. For example, an angular resolution of 15° may be achieved.
  • an EIM measurement system may employ a differential voltage driver that may be used to amplify a signal to a voltage level suitable for application to muscle tissue. Differential signals may be applied to the muscle tissue to reduce common mode interference. This may increase the reliability of the impedance measurements taken with the EIM system.
  • a voltage driver shown in FIG. 21 may perform several functions.
  • the voltage driver may convert the single-ended signal from the arbitrary waveform generator to a differential signal which may be applied to muscle tissue.
  • the voltage driver may also control amount of current delivered into the muscle tissue to ensure that the amount remains within patient safety limits.
  • an input stage comprises an emitter coupled transistor pair (Q1, Q2) which converts the single-ended input signal to a differential signal.
  • the signal then passes through the output stage which consists of two transistors in feedback with the base of Q3 connected to the emitter of Q4 and the base of Q4 connected to the collector of Q3.
  • a gain around the feedback loop may be approximately unity but the impedance looking into the emitter of Q4 may be quite small and given by: R out ⁇ 1 / g m 3 g m 4 r o 3 ⁇ R d 3 , where gm3 and gm4 are the transconductances of Q3 and Q4 and r o3 is the output resistance of Q3, respectively.
  • the small impedance at the emitter of Q4 makes this transistor pair a suitable output stage for the voltage driver circuit. It may ensure that very little potential is dropped across the output resistance of the voltage driver so that most of the potential may be dropped across muscle tissue.
  • FIG. 22 shows a differential voltage driver according to another embodiment of the invention.
  • This voltage driver may be, for example, a low output impedance voltage driver.
  • an input signal may be applied though a "sense" resistor.
  • a voltage across the sense resistor indicates the current injected.
  • stray capacitance may cause a phase shift in the measured voltage that is not due to properties of the tissue, which may compromise integrity of the impedance measurements.
  • the voltage driver shown in FIG. 22 may perform several functions. Thus, it may convert the single-ended signal from the arbitrary waveform generator to a differential signal which may be applied to muscle tissue. Also, for patient safety, injected current may be limited by current sources at emitters of Q3 and Q5.
  • the input stage consists of an emitter coupled transistor pair (Q1, Q2) which may convert the single-ended input signal to a differential signal.
  • the signal may then pass through the output stage which consists of a cascode device, transistor Q4 and an emitter follower, Q3.
  • the base of Q4 may be connected to the emitter of Q3 and the base of Q3 may be connected to the collector of Q4 (Q5 and Q6 may be identically connected). Using this structure, the base of Q4 may be biased without using another resistor chain.
  • the small output impedance, R out , of the voltage driver may ensure that most of the excitation signal may be dropped across muscle tissue.
  • a composite signal containing a number of sinusoids with logarithmically spaced frequencies may be used as a signal applied to muscle tissue.
  • impedance of the muscle tissue under investigation may be measured at multiple frequencies simultaneously.
  • muscle tissue acts as a linear medium with respect to current excitation makes this approach possible.
  • a speed of measurement may be increased as compared to an EIM measurement system in which impedance measurements are taken at each frequency sequentially.
  • one of the parameters that may be used to monitor a progress of neuromuscular disease is a change in a phase of the measured impedance over time.
  • This above information may be obtained by taking the Fourier transform of the measured and digitized voltages and performing required numerical computation in the frequency domain.
  • a MATLAB® script was written to extract the Fourier transform values at the frequencies selected a priori at which impedance information may be measured.
  • the current flowing through the muscle tissue may be obtained by measuring the voltage across the sense resistor, R sense as shown, for example, in FIGs. 21 and 22 .
  • the impedance of the muscle tissue may then be computed by taking a ratio of the voltage to the current at each frequency.
  • FIG. 23 shows exemplary time domain and frequency domain (Fourier transform) representation of a composite signal composed of 40 sinusoids with logarithmically spaced frequencies.
  • the signal may be generated, for example, using the EIM measurement system described in connection with FIGs. 12 , 13 and 21 .
  • An amplitude roll off exemplified in the frequency plot in FIG. 23 shows the low pass transfer function of a voltage driver circuit.
  • Spectral leakage of numerical values into adjacent frequency bins is apparent in the Fourier transform of the measured signals.
  • these tones may need to share an integer factor relationship with the ratio of sampling frequency to number of sample points. In this scenario, this requirement may be relaxed because frequencies at which impedance information is measured are known.
  • a MATLAB® script was written to extract the Fourier transform values at the desired frequencies thus eliminating the effect of spectral leakage. It should be appreciated that this may be performed using any suitable means.
  • FIG. 25 shows a time domain and frequency domain (Fourier transform) representation of a measured composite signal composed of 40 sinusoids with logarithmically spaced frequencies. This signal may be generated, for example, using the EIM measurement system described in connection with FIGs. 14 , 15 and 22 .
  • the amplitude roll off shown in the frequency plot is an artifact of the finite bandwidth of the voltage driver circuit.
  • results of EIM measurements in accordance with some embodiments of the invention may be displayed to a user (e.g., a physician or other medical practitioner) of the EIM measurement system on a suitable display.
  • the display may comprise any suitable graphical user interface which may be used for visualization and analysis of the results.
  • the results may be displayed during operation of the EIM measurement system. Accordingly, the user may view the results of EIM measurements and to thus monitor a progress of analyzing a region of tissue of the patient. Also, the EIM measurement system may monitor the progress of the EIM measurements automatically and may automatically determine when data sufficient to analyze condition of muscle is collected.
  • data comprising the results of EIM measurements may be analyzed using different data analysis techniques that allow determining patterns within the data indicative of different muscle conditions.
  • FIGs. 26-28 In order to assess potential clinical value of the EIM measurement system described above, particularly, in connection with FIGs. 14-16 and 22 , institutional review board approval was obtained at Beth Israel Deaconess Medical Center and three individuals were enrolled in the study after signing an approved consent form.
  • the results obtained using the above system are shown in FIGs. 26-28 , in which data obtained from biceps of a normal subject, a patient with amyotrophic lateral sclerosis (ALS) and a patient with inclusion body myositis are displayed, respectively.
  • the data are taken at logarithmically spaced frequencies between 10kHz and 300kHz and at angular increments of 30° from -90° to 90°. Effort was made to orient the 0° axis of the electrode array as close to the main muscle fiber direction as possible.
  • ALS amyotrophic lateral sclerosis
  • the normal subject demonstrates a relative subtle anisotropy in both the resistance and reactance plots (x-axis).
  • a clear frequency dependence is also present, with lower values at higher frequencies for both parameters.
  • this normal frequency dependence is altered, most notably in the reactance, where the values appear to increase at higher frequencies.
  • reactance curves slope upward and to the right.
  • the absolute value of both the measured reactance and resistance are offset from those observed in the healthy subject.
  • FIGs. 26-28 also illustrate that, in addition to the changes in the frequency dependence, the anisotropic character of the tissue is also different. Since the probe was oriented such that 0° was the major muscle fiber direction in all three individuals, it was anticipated that the lowest resistance and reactance values would occur at that angle. Indeed, in the healthy subject, this general shape of the anisotropy is apparent in both the reactance and resistance traces, as shown in FIG. 26 . However, in the ALS patient, a marked distortion and accentuation of the anisotropy of the resistance is observed, with an elevation in the overall values and a minimum at -60° rather than at 0°, as shown in FIG. 27 .
  • the anisotropy actually appears more modest than either the normal subject or the ALS patient, as shown in FIG. 28 . Both of these findings illustrate that the anisotropy may be elevated in neurogenic diseases and reduced in myopathic diseases.
  • Fig. 29 illustrates schematically an EIM probe which allows obtaining measurements in addition to impedance measurements, in accordance with some embodiments of the invention.
  • an electrode array 2900 of the EIM probe is illustrated, which may be mounted on a suitable base 2910.
  • Base 2910 may be positioned on a head of the EIM probe.
  • electrode array 2900 may comprise a plurality of current-injecting electrodes 2912 arranged in an outer ring and a plurality of voltage-measuring electrodes 2914 and 2916 arranged in two respective inner rings. Any suitable number of electrodes may form each of the rings, with different rings having the same or different number of electrodes.
  • the electrodes may be of any suitable size and shape and may be manufactured from any suitable material.
  • electrode array 2900 may comprise any suitable number of rings dedicated to injecting current or measuring voltage. As discussed above, electrode array 2900 may be reconfigurable. Thus, different combinations of excitation and pickup electrodes may be selected so that the electrodes are applied to a region of a tissue of a patient at multiple different orientations with respect to a direction of the muscle fibers. The different combinations of the electrodes may be selected during EIM measurements or at any other suitable time.
  • An EIM measurement system in accordance with some embodiments of the invention may obtain, in addition to impedance measurements of a region of tissue using an EIM probe, measurements of other different characteristics of the region of tissue. These characteristics may include, for example, a temperature of the skin, moisture content of the skin and any other suitable characteristics. Also, ultrasound, electrical tomography and other measurements may be performed at a region of tissue to which the EIM probe is applied. Furthermore, in some embodiments, a degree of pressure with which the EIM probe is applied to a region of tissue may be measured. The EIM measurements may be adjusted based on values indicative of different characteristics of the tissue obtained from the additional measurements.
  • FIG. 29 illustrates that a suitable sensor 2918 may be placed in proximity to electrode array 2900.
  • the sensor is shown to be placed at a center of electrode array 2900.
  • the sensor may be, for example, at least one temperature sensor, at least one pressure sensor, at least one moisture sensor, or at least one ultrasound sensor. It should be appreciated that, even though one sensor 2918 is shown in FIG. 29 , more than one sensor may be placed at suitable locations within the electrode array. For example, to monitor pressure with which the EIM probe is applied to a region of tissue, multiple pressure sensors may be placed at more than one location within the electrode array.
  • any suitable respective device may be used as each of the sensors.
  • the sensors may be associated with the EIM probe in any suitable manner.
  • one or more sensors may be incorporated at a head of the EIM probe.
  • the EIM measurements may be supplemented with electrical impedance tomography measurements collected by any suitable device.
  • electrodes of the electrode array in any suitable configuration, may be used to perform the electrical impedance tomography measurements.
  • the EIM measurement system may detect a degree of contact of each electrode of the electrode array 2900 with the surface of the skin in a region of tissue to which the EIM probe is being applied.
  • the degree of contact may be detected in any suitable manner. For example, strength of the signal collected as a result of application of current via excitation electrodes may be used as an indication of the degree of contact.
  • the electrode array of the EIM probe may comprise two or more sets of electrodes, where each set comprises excitation and pickup electrodes and the sets may simultaneously be used to determine muscle conditions at more than one location. As such, conditions of muscles at different depths beneath the skin surface may be assessed. Electrodes of different shapes and sizes, as well as forming different configurations (e.g., rings of different radii) may be used in the sets.
  • FIG. 30 illustrates schematically an example of an electrode array 3000, which may be located on base 2910 and may include, similarly to electrode array 2900, one or more sensors 2918.
  • electrodes 2920 forming the outermost ring may be excitation electrodes and electrodes 2922 forming a ring within the outermost ring may be pickup electrodes. Electrodes 2920 and 2922 may be used to detect conditions of muscles at larger depths underneath the skin surface. Distortions in the results of the measurements due to skin-subcutaneous fat may be accounted for.
  • electrodes 2924 forming a ring within electrodes 2922 may be excitation electrodes and electrodes 2926 forming the innermost ring may be pickup electrodes. Electrodes 2924 and 2926, shown for the clarity of the presentation in grey shade, may be used to detect conditions of muscles at smaller depths underneath the skin surface. Distortions in the results of the measurements due to skin-subcutaneous fat may be accounted for.
  • different data analysis techniques may be utilized to analyze results of impedance measurements and measurements of other parameters obtained using the EIM system described herein. Regardless of how data on a region of tissue is obtained, the data may be analyzed in any suitable way. For example, different three-dimensional and other plots may be generated for assessment of muscle condition. Also, results of EIM measurements may be combined in a suitable manner with results of additional measurements (e.g., measurements obtained using sensors). Results obtained for a healthy muscle may be compared to results of measurements obtained from a region of interest.
  • results obtained for a relatively healthy muscle within the same patient may be compared to the results of measurements obtained from the region of interest. Any other suitable measurements may be compared. Also, the EIM measurements and the measurements of other parameters maybe compared to suitable respective values (e.g., thresholds).
  • three-dimensional plots demonstrating frequency-angle-impedance i.e., resistance (R), reactance (X) and a phase ( ⁇ )
  • R resistance
  • X reactance
  • ⁇ phase
  • Such plots may be used for qualitative assessment of muscle condition.
  • a user such as a physician may visually detect distortions and difference between results obtained on healthy and diseased muscles.
  • acute or subacute neurogenic disorders i.e., nerve disorders
  • Other diseases such as more chronic neurogenic disorders or primary disorders of muscle, may reduce the measured anisotropy and also cause a more prominent elevation in reactance and phase at higher frequencies.
  • a variety of other possible combinations of changes may also occur.
  • the EIM measurements may be analyzed to detect that anisotropy of the muscle may be elevated when the muscle is affected by a neurogenic disease and may be reduced when the muscle is affected by a myopathic disease. Furthermore, the EIM measurements may be used to detect a change in a dependency of characteristics of muscle tissue obtained using the EIM measurement system on the frequency of the applied signal, where the change may be indicative of an abnormal condition of the muscle tissue.
  • the characteristics of muscle tissue may comprise resistance, reactance and any other suitable characteristic.
  • FIG. 31 illustrates, as an example, four cylindrical plots generated based on results of EIM measurements conducted on biceps of a healthy patient (plots A and B) and on biceps of a patient with ALS (plots C and D).
  • Plots A and C illustrate resistance and plots B and D illustrate reactance.
  • FIG. 31 shows that both resistance plot C and reactance plot D for the ALS patient exhibit distortion as compared to resistance plot A and reactance plot B for the healthy patient. Accordingly, identifying a distortion in plots generated on EIM measurements as compared to analysis of similar values for a healthy patient may be used as an indication of changes in the muscle. The degree of the changes may be determined based on a degree and a specific pattern of the distortion.
  • FIG. 32 illustrates results of EIM measurements for a patient with radiculopathy of the right side.
  • the EIM measurements on both tibialis anterior muscles are illustrated.
  • the difference in reactance (plots A and C) and resistance (plots B and D) between measurements on relaxed and contracted muscle is plotted.
  • Plots A and B show the difference between the relaxed and contracted states of healthy tibialis anterior muscle
  • plots B and C show the difference between the relaxed and contracted states of tibialis anterior muscle affected by radiculopathy.
  • clear differences may be observed between the respective differences in measurements on relaxed and contracted muscle of a healthy and diseased muscle. Accordingly, assessing the difference between EIM measurements on relaxed and contracted states of healthy and diseased muscles, respectively, may help identify changes in muscle conditions.
  • more complex algorithms may be utilized to accurately diagnose a disease or an abnormal condition, measure disease progression or improvement or a type of a disease present.
  • Such algorithms may use a combination of factors, including the multi-frequency, multi-angular measurements with contraction and correction for temperature and pressure as well as skin-subcutaneous fat thickness (obtained using the multiple concentric rings described above, via ultrasound measurements, or using any other suitable techniques).
  • the three-dimensional plots generated from impedance measurements obtained using the EIM probe may be used to derive into simple scores can be developed that would allow for rapid assessment of whether a condition is worsening, stabilizing, or improving over time or to assist with specific disease analysis. Once derived, such "EIM scores" may provide convenient measures of a disease type and a disease status.
  • the EIM measurement system using the EIM probe in accordance with some embodiments of the invention may be used to obtain impedance measurements of a region of tissue for any suitable purposes that are not limited to detection and diagnosis of a disease. Because the EIM measurement system described herein may help to detect changes in a structure of the underlying muscle, the system may be useful in a variety of different applications.
  • the data analysis techniques described above may be used to demonstrate distortions in the impedance measurements indicative of the changes in the muscle. Any other suitable data analysis techniques may be used as well.
  • the impedance measurements may be employed to asses improvement in muscle condition (e.g., due to exercises) beyond a certain point, which may be referred to as a baseline. This may be used by professional athletes or any other people involved in physical training whose muscle condition may be monitored to track and assess progress of the training. In such situations, EIM measurements may be conducted on contracted and relaxed muscles. Also, the EIM measurements may be used for assessment of muscle conditions indicative of potential muscle overuse injury and other disorders.
  • the EIM measurements using the EIM probe in accordance with some embodiments of the invention may also be used to assess changes in muscle caused by disuse of the muscle which may happen because of an orthopedic or other injury, weightlessness (e.g., due to a prolonged exposure to microgravity) and other conditions. Also, stages of recovery from these conditions may be tracked and assessed. Also, the EIM probe may be used to monitor and adjust a course of rehabilitation after injury or after surgery (e.g. joint replacement).
  • the EIM probe may be used to detect muscle injury caused by trauma and/or bleeding. Also, because metallic (e.g., shrapnel) and non-metallic objects embedded in skin, subcutaneous fat or muscle may distort the impedance measurements, such discrete objects may be localized using the EIM measurements. The electrode array of the EIM probe may need to be reconfigured for such detection.
  • sarcopenia or muscle atrophy and weakness due to aging and other factors (e.g., lack of physical activity) may be detected.
  • Sarcopenia presents one of the major health concern in Western societies in which life expectancy has increased.
  • Pharmaceutical companies undertake large efforts to develop drugs to inhibit or reverse the effects of sarcopenia.
  • the impedance measurements and their analysis may be employed to detect and monitor different degrees of sarcopenia present and may help direct efforts for treating this condition, including developing a therapy.
  • the EIM probe may be used to assess muscle condition not only in humans but may also be employed for various veterinary uses. Assessing muscle condition using this non-invasive technique may be useful in animals, especially race horses and dogs. Muscle conditions of cattle raised for food may also be evaluated.
  • the EIM probe may be adapted to be applied to a region on tissue in an animal - for example, electrodes of the electrode array may be modified to allow the probe to penetrate through the fur or hair. Also, other modification to the EIM probe may be made to make the probe suitable for veterinary uses.
  • the EIM probe may be used to assess quality of food, such as various types of meat.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Claims (15)

  1. Procédé pour déterminer, par myographie d'impédance électrique, au moins une première caractéristique d'une région de tissu, le procédé comprenant :
    mesurer la qualité de contact d'électrode d'une première et d'une deuxième pluralité d'électrodes ;
    reconfigurer automatiquement les première et deuxième pluralités d'électrodes sur la base de la qualité de contact d'électrode mesurée pour exclure une ou plusieurs électrodes des première et deuxième pluralités d'électrodes ;
    sélectionner au moins une première paire de la première pluralité d'électrodes pour appliquer un premier signal électrique comprenant une pluralité de fréquences à la région de tissu, les électrodes de ladite au moins une première paire étant dans une première orientation par rapport aux fibres musculaires ;
    détecter au moins une valeur d'au moins une deuxième caractéristique de la région de tissu pendant un temps où le premier signal électrique est appliqué à la région de tissu ;
    sélectionner au moins une deuxième paire de la deuxième pluralité d'électrodes pour détecter un deuxième signal électrique au niveau de la région de tissu résultant de l'application du premier signal électrique par ladite au moins une première paire, les électrodes de ladite au moins une deuxième paire étant dans une première orientation, la première pluralité d'électrodes étant reconfigurable pour sélectionner au moins une troisième paire de la première pluralité d'électrodes pour appliquer le premier signal électrique à la région de tissu, les électrodes de ladite au moins une troisième paire étant dans une deuxième orientation par rapport aux fibres musculaires ; et la deuxième pluralité d'électrodes étant reconfigurable pour sélectionner au moins une quatrième paire de la deuxième pluralité d'électrodes pour détecter le deuxième signal électrique au niveau de la région de tissu résultant de l'application du premier signal électrique par ladite au moins une troisième paire, les électrodes de ladite au moins une quatrième paire étant dans une deuxième orientation ; et
    ajuster le deuxième signal électrique sur la base de ladite au moins une valeur de ladite au moins une deuxième caractéristique.
  2. Procédé selon la revendication 1, dans lequel ladite au moins une deuxième caractéristique comprend au moins une caractéristique choisie dans le groupe constitué de la température, la teneur en humidité et un degré de pression avec lequel la première pluralité d'électrodes et la deuxième pluralité d'électrodes sont appliquées à une surface de la région de tissu.
  3. Procédé selon la revendication 2, dans lequel la pression avec laquelle la première pluralité d'électrodes et la deuxième pluralité d'électrodes sont appliquées à une surface de la région est ajustée sur la base du degré de pression.
  4. Procédé selon l'une quelconque des revendications 1 à 3, comprenant en outre la détection d'un degré de contact entre chaque électrode de la première pluralité d'électrodes et de la deuxième pluralité d'électrodes et une surface de la région de tissu.
  5. Procédé selon la revendication 4, comprenant en outre, lorsque qu'il est détecté qu'au moins une électrode d'au moins l'une de la première pluralité d'électrodes et de la deuxième pluralité d'électrodes a un degré de contact en dessous d'un seuil prédéterminé, reconfigurer au moins l'une de la première pluralité d'électrodes et de la deuxième pluralité d'électrodes pour sélectionner au moins l'une de ladite au moins une troisième paire et de ladite au moins une quatrième paire pour exclure ladite au moins une électrode.
  6. Procédé selon l'une quelconque des revendications 1 à 5, comprenant en outre une reconfiguration de la première pluralité d'électrodes pour sélectionner ladite au moins une troisième paire, et de la deuxième pluralité d'électrodes pour sélectionner ladite au moins une quatrième paire, sur la base de ladite au moins une valeur de ladite au moins une deuxième caractéristique.
  7. Procédé selon l'une quelconque des revendications 1 à 6, comprenant en outre :
    générer au moins un tracé représentatif d'au moins un paramètre du deuxième signal électrique ajusté ; et
    utiliser ledit au moins un tracé pour détecter au moins un élément caractéristique indicatif de ladite au moins une première caractéristique de la région de tissu.
  8. Procédé selon la revendication 7, dans lequel le tracé comprend au moins un tracé tridimensionnel et ledit au moins un élément caractéristique indicatif de ladite au moins une première caractéristique comprend au moins une distorsion dans ledit au moins un tracé tridimensionnel.
  9. Système de mesure EIM (myographie d'impédance électrique) pour déterminer, par myographie d'impédance électrique, un état musculaire d'une région de tissu, le système comprenant :
    une sonde portable comprenant :
    un corps comprenant une tête supportant une base ;
    une pluralité d'électrodes montée sur la base, la pluralité d'électrodes comprenant :
    au moins une première paire d'une première pluralité d'électrodes adaptée à appliquer un premier signal électrique comprenant une pluralité de fréquences à la région de tissu, les électrodes de ladite au moins une première paire étant dans une première orientation par rapport aux fibres musculaires ; et
    au moins une deuxième paire d'une deuxième pluralité d'électrodes pour détecter un deuxième signal électrique au niveau de la région de tissu résultant de l'application du premier signal électrique par ladite au moins une première paire, les électrodes de ladite au moins une deuxième paire étant dans la première orientation, dans lequel :
    le système de mesure EIM est agencé pour :
    - mesurer la qualité de contact d'électrode des première et deuxième pluralités d'électrodes ; et
    - reconfigurer automatiquement les première et deuxième pluralités d'électrodes sur la base de la qualité de contact d'électrode mesurée pour exclure une ou plusieurs électrodes des première et deuxième pluralités d'électrodes ; et
    la première pluralité d'électrodes est reconfigurable pour sélectionner au moins une troisième paire de la première pluralité d'électrodes pour appliquer le premier signal électrique à la région de tissu, les électrodes de ladite au moins une troisième paire étant dans une deuxième orientation par rapport aux fibres musculaires, et la deuxième pluralité d'électrodes étant reconfigurable pour sélectionner au moins une quatrième paire de la deuxième pluralité d'électrodes pour détecter le deuxième signal électrique au niveau de la région de tissu résultant de l'application du premier signal électrique par ladite au moins une troisième paire, les électrodes de ladite au moins une quatrième paire étant dans la deuxième orientation ; et
    au moins un capteur adapté à obtenir au moins une première valeur d'au moins une caractéristique de la région de tissu pendant un temps où le premier signal électrique est appliqué à la région de tissu.
  10. Système de mesure EIM selon la revendication 9, comprenant en outre un composant d'analyse adapté à analyser le deuxième signal électrique pour déterminer au moins une deuxième valeur indicative de l'état musculaire de la région de tissu, et à ajuster ladite au moins une deuxième valeur sur la base de ladite au moins une première valeur, ladite au moins une deuxième valeur ajustée étant indicative de l'état musculaire.
  11. Système de mesure EIM selon la revendication 9 ou 10, dans lequel ledit au moins un capteur comprend au moins un capteur choisi dans le groupe constitué d'au moins un capteur de température, au moins un capteur d'humidité, au moins un capteur d'ultrasons et au moins un capteur de tomographie électrique.
  12. Système de mesure EIM selon l'une quelconque des revendications 9 à 11, dans lequel les électrodes de la pluralité d'électrodes sont fixées de manière amovible à la base par l'intermédiaire d'un mécanisme de verrouillage, et dans lequel le dispositif comprend un mécanisme de libération pour détacher la pluralité d'électrodes de la base.
  13. Système de mesure EIM selon l'une quelconque des revendications 9 à 12, comprenant en outre un dispositif de mesure à ultrasons.
  14. Système de mesure EIM selon l'une quelconque des revendications 9 à 13, comprenant en outre un composant de commande pour commander la reconfiguration d'au moins l'une de la première pluralité d'électrodes et de la deuxième pluralité d'électrodes sur la base de ladite au moins une première valeur d'au moins une caractéristique.
  15. Système de mesure EIM selon la revendication 14, dans lequel le composant de commande est adapté à commander la reconfiguration d'au moins l'une de la première pluralité d'électrodes et de la deuxième pluralité d'électrodes automatiquement, en réponse à la détection de ladite au moins une première valeur d'au moins une caractéristique.
EP10748158.2A 2009-08-21 2010-08-20 Dispositif portatif pour myographie d impédance électrique Active EP2467059B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23600909P 2009-08-21 2009-08-21
PCT/US2010/002295 WO2011022068A1 (fr) 2009-08-21 2010-08-20 Dispositif portatif pour myographie d’impédance électrique

Publications (2)

Publication Number Publication Date
EP2467059A1 EP2467059A1 (fr) 2012-06-27
EP2467059B1 true EP2467059B1 (fr) 2019-11-06

Family

ID=43063593

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10748158.2A Active EP2467059B1 (fr) 2009-08-21 2010-08-20 Dispositif portatif pour myographie d impédance électrique

Country Status (3)

Country Link
US (2) US9974463B2 (fr)
EP (1) EP2467059B1 (fr)
WO (1) WO2011022068A1 (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ113799A0 (en) 1999-06-22 1999-07-15 University Of Queensland, The A method and device for measuring lymphoedema
WO2005122888A1 (fr) 2004-06-18 2005-12-29 The University Of Queensland Detection d'oedeme
EP1898784B1 (fr) 2005-07-01 2016-05-18 Impedimed Limited Procédé et dispositif destinés à des mesures d'impedance
EP1898782B1 (fr) 2005-07-01 2016-04-06 Impedimed Limited Système de surveillance
US20100292603A1 (en) * 2005-09-21 2010-11-18 Beth Israel Deaconess Medical Center, Inc. Electrical Impedance Myography
US9724012B2 (en) 2005-10-11 2017-08-08 Impedimed Limited Hydration status monitoring
US8761870B2 (en) 2006-05-30 2014-06-24 Impedimed Limited Impedance measurements
AU2007327573B2 (en) 2006-11-30 2013-07-18 Impedimed Limited Measurement apparatus
WO2008128281A1 (fr) 2007-04-20 2008-10-30 Impedimed Limited Système et sonde de surveillance
US8836345B2 (en) 2007-11-05 2014-09-16 Impedimed Limited Impedance determination
US20160157749A1 (en) * 2013-08-25 2016-06-09 Skulpt, Inc. Systems and methods for measurement of bioimpedance
US11246504B2 (en) * 2007-12-07 2022-02-15 Myolex Inc. Enhanced measurements of bioimpedance
AU2008207672B2 (en) 2008-02-15 2013-10-31 Impedimed Limited Impedance Analysis
US9615766B2 (en) 2008-11-28 2017-04-11 Impedimed Limited Impedance measurement process
WO2011022068A1 (fr) 2009-08-21 2011-02-24 Rutkove Seward B Dispositif portatif pour myographie d’impédance électrique
JP5643829B2 (ja) 2009-10-26 2014-12-17 インぺディメッド リミテッドＩｍｐｅｄｉｍｅｄ Ｌｉｍｉｔｅｄ インピーダンス測定の分析において用いるための方法及び装置
AU2010321683B2 (en) 2009-11-18 2014-06-26 Impedimed Limited Signal distribution for patient-electrode measurements
JP5669139B2 (ja) * 2010-04-05 2015-02-12 国立大学法人東京工業大学 生体インピーダンス測定装置
US8990040B2 (en) * 2010-12-22 2015-03-24 General Electric Company System and method for correcting fault conditions in soft-field tomography
WO2012149471A2 (fr) 2011-04-28 2012-11-01 Convergence Medical Devices Dispositifs et procédés pour évaluer un tissu
US9861293B2 (en) 2011-04-28 2018-01-09 Myolex Inc. Sensors, including disposable sensors, for measuring tissue
CN103997959B (zh) * 2011-09-21 2018-01-26 英戈·弗洛尔 诊断测量装置
US8781565B2 (en) * 2011-10-04 2014-07-15 Qualcomm Incorporated Dynamically configurable biopotential electrode array to collect physiological data
JP2013183767A (ja) * 2012-03-06 2013-09-19 Tanita Corp 筋機能評価方法及び筋機能評価装置
GB201213592D0 (en) 2012-07-27 2012-09-12 Univ Southampton Apparatus for use for providing information on at least one muscle in a patent
US20130035606A1 (en) * 2012-10-09 2013-02-07 Wichner Brian D Multi-Wave Signals to Reduce Effects of Electrode Variability
US9378655B2 (en) 2012-12-03 2016-06-28 Qualcomm Incorporated Associating user emotion with electronic media
KR102059346B1 (ko) * 2013-03-05 2020-02-11 삼성전자주식회사 근전도 센서 시스템 및 근전도 센서 시스템의 동작 방법
AU2014284130B2 (en) * 2013-06-19 2020-02-06 Ti2 Medical Pty Ltd Methods and apparatuses for characterisation of body tissue
JP2016533835A (ja) * 2013-08-25 2016-11-04 スカルプト インコーポレイテッドＳｋｕｌｐｔ，Ｉｎｃ． 身体組織の生体インピーダンス関連特性を測定して身体および身体領域の脂肪率および筋肉率ならびに筋肉クオリティを表示する装置および方法
WO2015031490A1 (fr) * 2013-08-27 2015-03-05 Repro-Med Systems, Inc. Procédé de sélection d'une aiguille pour la thérapie sous-cutanée
US10729379B2 (en) * 2013-10-22 2020-08-04 The Regents Of The University Of California Electrical wearable capacitive biosensor and noise artifact suppression method
WO2015123603A1 (fr) * 2014-02-14 2015-08-20 Beth Israel Deaconess Medical Center, Inc. Myographie d'impédance électrique
CN103876738B (zh) * 2014-04-03 2016-03-09 思澜科技（成都）有限公司 基于频谱特性的生物阻抗测量探针、测量系统及方法
FI125745B (fi) * 2014-07-18 2016-01-29 Maricare Oy Anturijärjestely
WO2016099824A1 (fr) * 2014-11-24 2016-06-23 Skulpt, Inc. Systèmes et procédés de mesure de bio-impédance
EP3244791A4 (fr) * 2015-01-14 2018-07-18 RS Medical Monitoring Ltd. Procédé et système de surveillance de l'impédance électrique interne d'un objet biologique
WO2017074378A1 (fr) * 2015-10-29 2017-05-04 Aaron Arthur A Appareil, système et procédé utilisant des mesures d'impédance et des images pour la détection de maladies
GB2545703B (en) 2015-12-22 2019-01-09 Univ Sheffield Apparatus and methods for determining force applied to the tip of a probe
US10368756B2 (en) * 2015-12-31 2019-08-06 BioPause LLC Sensing circuit with cascaded reference
ES2950501T3 (es) * 2016-04-22 2023-10-10 Fitskin Inc Sistemas para el análisis de la piel mediante dispositivos electrónicos
US10983507B2 (en) 2016-05-09 2021-04-20 Strong Force Iot Portfolio 2016, Llc Method for data collection and frequency analysis with self-organization functionality
US11774944B2 (en) 2016-05-09 2023-10-03 Strong Force Iot Portfolio 2016, Llc Methods and systems for the industrial internet of things
US10712738B2 (en) 2016-05-09 2020-07-14 Strong Force Iot Portfolio 2016, Llc Methods and systems for industrial internet of things data collection for vibration sensitive equipment
US11327475B2 (en) 2016-05-09 2022-05-10 Strong Force Iot Portfolio 2016, Llc Methods and systems for intelligent collection and analysis of vehicle data
US10531823B2 (en) 2016-05-24 2020-01-14 Hill-Rom Services, Inc. Systems and methods for generating notifications based on bladder volume signals and bladder muscle signals
DE102016006329B3 (de) * 2016-05-24 2018-02-01 Robin Fox Vorrichtungsanordnung zur Erfassung körperlicher Leistungswerte eines Probanden sowie Verfahren zur Ermittlung körperlicher Leistungswerte eines Probanden
JP6709462B2 (ja) * 2016-06-10 2020-06-17 公益財団法人ヒューマンサイエンス振興財団 行動体力評価装置、行動体力評価装置の作動方法及びプログラム
US11237546B2 (en) 2016-06-15 2022-02-01 Strong Force loT Portfolio 2016, LLC Method and system of modifying a data collection trajectory for vehicles
DE102016114611A1 (de) * 2016-08-07 2018-02-08 Karl-Heinz Fromm Elektrodenanordnung, insbesondere für die Elektrische Impedanz Tomographie
US11378534B2 (en) * 2016-10-31 2022-07-05 Samsung Electronics Co., Ltd. Method for measuring change of cell in real time and device therefor
US10485502B2 (en) * 2016-12-20 2019-11-26 General Electric Company System and method for assessing muscle function of a patient
WO2018213495A1 (fr) 2017-05-16 2018-11-22 Beth Israel Deaconess Medical Center, Inc. Électromyographie à impédance avec aiguille et imagerie d'impédance électrique pour diagnostics musculaires améliorés
US10921801B2 (en) 2017-08-02 2021-02-16 Strong Force loT Portfolio 2016, LLC Data collection systems and methods for updating sensed parameter groups based on pattern recognition
CA3072045A1 (fr) 2017-08-02 2019-02-07 Strong Force Iot Portfolio 2016, Llc Procedes et systemes de detection dans un environnement industriel de collecte de donnees d'internet des objets avec de grands ensembles de donnees
US11109787B2 (en) * 2018-05-21 2021-09-07 Vine Medical LLC Multi-tip probe for obtaining bioelectrical measurements
CN109145706A (zh) * 2018-06-19 2019-01-04 徐州医科大学 一种用于振动信号分析的敏感特征选取与降维方法
WO2020053703A1 (fr) * 2018-09-10 2020-03-19 Alma Mater Studiorum - Universita' Di Bologna Système d'impédance pour l'évaluation de la masse musculaire
KR20210095145A (ko) * 2018-10-23 2021-07-30 에스테틱스 바이오메디컬, 인크. 콜라겐 재생을 유도하는 방법, 장치 및 시스템
KR20210149375A (ko) * 2020-06-02 2021-12-09 삼성전자주식회사 임피던스 측정 장치 및 방법과, 체내 물질 성분 분석 장치
KR102412414B1 (ko) * 2020-06-30 2022-06-23 연세대학교 산학협력단 미세전극 어레이부가 구비된 신경신호 피드백 시스템 및 신경신호 피드백 방법
CN111789592B (zh) * 2020-06-30 2022-04-05 杭州电子科技大学 一种基于拓扑特征融合的脑电识别方法
CN115177234B (zh) * 2022-07-11 2023-08-01 济纶医工智能科技(南京)有限公司 一种高密度传感器、高密度检测装置、数据处理方法以及成像方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6122544A (en) * 1998-05-01 2000-09-19 Organ; Leslie William Electrical impedance method and apparatus for detecting and diagnosing diseases
US6602201B1 (en) 2000-07-10 2003-08-05 Cardiodynamics International Corporation Apparatus and method for determining cardiac output in a living subject
SE518253C2 (sv) 2001-01-22 2002-09-17 Britta Sethson Anordning för klinisk impedansmätning av hud där en mätprob är utformad med sensorer för att känna av den lokala mätmiljön
DE10136529C1 (de) 2001-07-26 2002-12-12 Siemens Ag Kombinierter elektrischer Impedanz- und Ultraschall-Scanner
WO2003026525A1 (fr) * 2001-09-28 2003-04-03 Rita Medical Systems, Inc. Appareil et procede d'ablation de tissu commandes par impedance
US20040019292A1 (en) * 2002-07-29 2004-01-29 Drinan Darrel Dean Method and apparatus for bioelectric impedance based identification of subjects
JP2005198849A (ja) * 2004-01-16 2005-07-28 Tanita Corp インピーダンス式筋力測定装置
WO2006044868A1 (fr) * 2004-10-20 2006-04-27 Nervonix, Inc. Systeme de discrimination tissulaire, base sur une bio-impedance, a electrode active et ses methodes d'utilisation
US20100292603A1 (en) 2005-09-21 2010-11-18 Beth Israel Deaconess Medical Center, Inc. Electrical Impedance Myography
US9724012B2 (en) * 2005-10-11 2017-08-08 Impedimed Limited Hydration status monitoring
EP1954175B1 (fr) * 2005-11-10 2016-07-13 Biovotion AG Dispositif permettant de determiner le niveau de glucose dans un tissu corporel
JP2008136655A (ja) 2006-12-01 2008-06-19 Omron Healthcare Co Ltd 脈波測定用電極ユニットおよび脈波測定装置
WO2011022068A1 (fr) 2009-08-21 2011-02-24 Rutkove Seward B Dispositif portatif pour myographie d’impédance électrique
WO2015123603A1 (fr) 2014-02-14 2015-08-20 Beth Israel Deaconess Medical Center, Inc. Myographie d'impédance électrique
WO2018213495A1 (fr) 2017-05-16 2018-11-22 Beth Israel Deaconess Medical Center, Inc. Électromyographie à impédance avec aiguille et imagerie d'impédance électrique pour diagnostics musculaires améliorés

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US9974463B2 (en) 2018-05-22
US20190069801A1 (en) 2019-03-07
US11589766B2 (en) 2023-02-28
WO2011022068A1 (fr) 2011-02-24
US20120245436A1 (en) 2012-09-27
EP2467059A1 (fr) 2012-06-27

Similar Documents

Publication Publication Date Title
US11589766B2 (en) Hand-held device for electrical impedance myography
US20210361185A1 (en) Electrical impedance myography
US10898100B2 (en) Electrical impedance myography
US7628761B2 (en) Apparatus and method for performing nerve conduction studies with localization of evoked responses
Rutkove et al. Electrical impedance methods in neuromuscular assessment: an overview
US9615766B2 (en) Impedance measurement process
US9037227B2 (en) Use of impedance techniques in breast-mass detection
Sanchez et al. Guidelines to electrode positioning for human and animal electrical impedance myography research
US10154795B2 (en) Controller for neuromuscular testing
US20230346286A1 (en) Needle impedance electromyography and electrical impedance imaging for enhanced muscle diagnostics
Narayanaswami et al. Utilizing a handheld electrode array for localized muscle impedance measurements
US9042976B2 (en) Use of impedance techniques in breast-mass detection
Rutkove et al. Test–retest reproducibility of 50 kHz linear-electrical impedance myography
Li et al. Electrical impedance myography changes after incomplete cervical spinal cord injury: an examination of hand muscles
Zheng et al. Abnormal flexor carpi radialis H-reflex as a specific indicator of C7 as compared with C6 radiculopathy
Luo et al. In vivo muscle conduction study of the tongue using a multi-electrode tongue depressor
US11109787B2 (en) Multi-tip probe for obtaining bioelectrical measurements
US9526432B2 (en) Enhanced surface and tip for obtaining bioelectrical signals
Maitland et al. Electrical cross-sectional imaging of human motor units in vivo
Bosnjak et al. Characterizing dry electrodes impedance by parametric modeling for arm wearable long-term cardiac rhythm monitoring
Ogunnika et al. A handheld electrical impedance myography probe for the assessment of neuromuscular disease
Kumar et al. Analysis and validation of medical application through electrical impedance based system
Fu et al. Estimating localized bio-impedance with measures from multiple redundant electrode configurations
Nandedkar Emerging techniques in the electrodiagnostic laboratory
Almokdad et al. Impact of reference electrode position on motor unit number estimation (MUNE) in the tibialis anterior muscle using MScanFit: test-retest reliability

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120321

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1172223

Country of ref document: HK

17Q First examination report despatched

Effective date: 20160406

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/00 20060101ALI20170929BHEP

Ipc: A61B 5/053 20060101AFI20170929BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190319

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTC Intention to grant announced (deleted)
GRAR Information related to intention to grant a patent recorded

Free format text: ORIGINAL CODE: EPIDOSNIGR71

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

INTG Intention to grant announced

Effective date: 20190926

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1197666

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191115

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010061824

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20191106

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200207

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200206

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200206

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200306

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200306

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010061824

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1197666

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20200807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200820

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200820

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191106

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230527

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240828

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240827

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240826

Year of fee payment: 15